MAPT and Alzheimer disease: YAP was downregulated in hippocampus tissue from a transgenic mouse model of AD pathology at early stages (2 months before Aβ or tau pathology) and in hippocampi from incipient AD patients [97], suggesting that YAP changes are present in early disease stages.